Association of Metabolic Syndrome Parameters with Kidney Stones in Indonesia
##plugins.themes.academic_pro.article.main##
Abstract
Kidney stone disease is common throughout the world. Elevated prevalence of kidney stones is often associated with metabolic syndrome itself. This study aimed to assess the association between kidney stones and metabolic syndrome parameters in differences gender. This was a cross-sectional study with Chi-square and multivariate logistic regression for data analysis from the secondary data Riskesdas 2013 with 26,063 respondents. Diagnosis of kidney stone based on Riskesdas 2013 interview, metabolic syndrome based on NCEP ATP-III and PERKENI. Result showed that there were 226 (0.9%) diagnosed kidney stones cases by doctors. After adjustment age, central obesity was dominant factor which associated with the risk of kidney stones in male (OR 1.9; 95% CI 1.3-2.9; p=0.003) and metabolic syndrome was dominant factor which associated with the risk of kidney stones in female (OR 6.1; 95% CI 3.4-11.3; p<0.001). The conclusion was that metabolic syndrome and central obesity were associated with risk of kidney stones.
##plugins.themes.academic_pro.article.details##
References
Cai, C., Mai, Z., Deng, T., Zhao, Z., Zhu, W., Wen, Y., & Duan, X. 2018. Impact of dyslipidemia on 24-h urine composition in adults without urolithiasis. Lipids in Health and Disease, 17: 1–8. https://doi.org/https://doi.org/10.1186/s12944-018-0899-x
Cameron, M., Maalouf, N. M., Poindexter, J., Adams-huet, B., Sakhaee, K., & Moe, O. W. 2012. The diurnal variation in urine acidification differs between normal individuals and uric acid stone formers. Kidney International, 81(11): 1123–1130. https://doi.org/10.1038/ki.2011.480
Chen, Z., Prosperi, M., & Bird, V. Y. 2018. Prevalence of kidney stones in the USA : The National Health and Nutrition Evaluation Survey. Journal of Clinical Urology, 1–7. https://doi.org/10.1177/2051415818813820
Cho, S. T., Jung, S.I., Myung, S. C., & Kim, T. H. 2013. Correlation of Metabolic Syndrome with Urinary Stone Composition. Int J Urol, 20: 208–213. https://doi.org/10.1111/j.1442-2042.2012.03131.x
Croppi, E., Ferraro, P., Taddei, L., & Gambaro, G. 2012. Prevalence of Renal Stones in an Italian Urban Population: A General Practice-Based Study. Urol Res, 40(5): 517–522. https://doi.org/10.1007/s00240-012-0477-z
Curhan, G. (2007). Epidemiology of Stone Disease. Urol Clin North Am, 34: 287–293. https://doi.org/doi:10.1016/j.ucl.2007.04.003.
Denburg, M. R., Jemeilita, T.O., Tasian, G.E., et al. 2015. Assessing the risk of incident hypertension and chronic kidney disease after exposure to shockwave lithotripsy and ureteroscopy. Kidney Int, 1–8. https://doi.org/10.1038/ki.2015.321
Eren, E., Yilmaz, N., & Aydin, O. 2012. High Density Lipoprotein and it’s Dysfunction. Biochemistry Journal, 6: 78–93. https://doi.org/doi:10.2174/1874091x01206010078
Farahdika, A., & Azam, M. 2015. Faktor Risiko yang Berhubungan dengan Penyakit Jantung Koroner pada Usia Dewasa Madya (41-60 Tahun) (Studi Kasus di RS Umum Daerah Kota Semarang). Unnes Journal of Public Health, 4(2). https://doi.org/doi.org/10.15294/ujph.v4i2.5188
Ferrari, C. 2007. Functional Foods and Physical Activities in Health Promotion of Aging People. Maturitas, 58 (4): 327–339. https://doi.org/10.1016/j.maturitas.2007.09.011
Ferraro, P., Taylor, E., & Eisner, B. 2013. History of Kidney Stones and The Risk of Coronary Heart Disease. JAMA, 310 (4): 408–415. https://doi.org/10.1001/jama.2013.8780
Hess, B. 2012. Metabolic Syndrome, Obesity and Kidney Stones. Arab J Urol, 10(3): 258–264. https://doi.org/10.1016/j.aju.2012.04.005
Hoofnagle, A., Vaisar, T., Mitra, P., & Chait, A. 2010. HDL Lipids and Insulin Resistance. Curr Diab Rep, 10 (1): 78–86. https://doi.org/10.1007/s11892-009-0085-7
Indonesia Health Ministry. 2013. Riset Kesehatan Dasar (Riskesdas) 2013. Retrieved from www.depkes.go.id/resources/download/general/Hasil Riskesdas 2013.pdf.
Jeong, I. G., Kang, T., Bang, J.K., et al. 2011. Association Between Metabolic Syndrome and the Presence of Kidney Stones in a Screened Population. Am J Kidney Dis, 58(3): 383–388. https://doi.org/10.1053/j.ajkd.2011.03.021
Jung, H. S., Chang, I.H., Kim, K.D., et al. 2011. Relationship between Metabolic Syndrome Traits and Nephrolithiasis : Incidence for 15 Years According to Gender. Korean J Urol, 52(8): 548–553.
Kim, Y., Kim, C., Shung, E., Kim, S., Shin, H., & Jung, W. 2013. Association of Nephrolithiasis with Metabolic Syndrome and its Components. Metabolism, 62(6): 808–813. https://doi.org/10.1016/j.metabol.2012.12.010
Kirejczyk, J.K., Porowski, T., Konstantynowicz, J. et al. 2014. Pediatr Nephrol, 29: 1575. https://doi.org/10.1007/s00467-014-2806-7
Kittanamongkolchai, W., Mara, K.C., Mehta, R.A., et al. 2017. Article Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers. Clin J Am Soc Nephrol, 12: 76–482. https://doi.org/10.2215/CJN.06600616
Kohjimoto, Y., Sasaki, Y., Iguchi, M., Matsumura, N., Inagaki, T., & Hara, I. 2013. Association of Metabolic Syndrome Traits and Severity of Kidney Stones : Results From a Nationwide Survey on. Am J Kidney Dis, 61(6): 923–929. https://doi.org/10.1053/j.ajkd.2012.12.028
Krivosikova, Z., Spustova, V., & Dzurik, K. 1998. Participation of P-dependent and P- independent Glutaminases in Rat Kidney Ammoniagenesis and Their Modulation by Metabolic Acidosis, Hippurate, and Insulin. Physiological Research, 47(3): 177-183.
Kum, F., Mahmalji, W., Hale, J., Thomas, K., & Bultitude, M. 2016. Do Stones Still kill? An Analysis of Death from Stone Disease 1999-2013 in England and Wales. BJU Int, 118(1): 140–144. https://doi.org/doi:10.1111/bju.13409
Li, H., Klett, D.E., Littleton, R., Elder, J.S., & Sammon, J.D. 2014. Role of Insulin Resistance in Uric Acid Nephrolithiasis. World Journal of Nephrology, 3(4): 237–242. https://doi.org/10.5527/wjn.v3.i4.237
Lin, S.-Y., Lin, C.-L., & Chang, Y.-J. 2016. Association Between Kidney Stones and Risk of Stroke: A Nationwide Population-Based Cohort Study. Medicine (Baltimore), 95(8): 2847. https://doi.org/10.1097/MD.0000000000002847
Moy, F. M., & Bulgiba, A. 2010. The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur. BMC Public Health, 10. https://doi.org/10.1186/1471-2458-10-678
Musa, R., & Idris, O. 2015. Association Between Dyslipidemia And Kidney Stone Risk In Sudanese Patients. Int J Sci Technol Res, 4(9).
NCEP-ATP III. 2003. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation , and Treatment of High Blood Colesterol in Adults (Adult Treatment Panel III). Executive Summary.
Otsuki, M., Kitamura, T., Goya, K., et al. 2011. Association of Urine Acidification with Visceral Obesity and the Metabolic Syndrome. Endocr J, 58(5): 363–367.
Perkumpulan Endokrinologi Indonesia. 2015. Panduan Pengelolaan Dislipidemia Di Indonesia. Jakarta: PB PERKENI.
Rendina, D., Mossetti, G., De Filippo, G., et al. 2009. Association Between Metabolic Syndrome and Nephrolithiasis in an Inpatient Population in Southern Italy: Role of Gender, Hypertension and Abdominal Obesity. Nephrol Dial Transplant, 24 (3): 900–906. https://doi.org/10.1093/ndt/gfn548
Scales, C., Smith, A., Hanley, J., & Saigal, C. 2012. Prevalence of Kidney Stones in the United States. Eur Urol, 62(1): 60–165. https://doi.org/10.1016/j.eururo.2012.03.052
Sidorenkov, O., Nilssen, O., Brenn, T., Martiushov, S., Arkhipovsky, V. L., & Grjibovski, A. M. 2010. Prevalence of the metabolic syndrome and its components in Northwest Russia : the Arkhangelsk study. BMC Public Health, 10(23): 1–9.
Sorensen, M.D., Chi, T., Shara, N.M., et al. 2014. Activity, Energy Intake, Obesity, and the Risk of Incident Kidney Stones in Postmenopausal Women: a Report from the Women’s Health Initiative. J Am Soc Nephrol, 25: 362–369. https://doi.org/10.1681/ASN.2013050548
Taylor, E., & Curhan, G. 2006. Diet and Fluid Prescription in Stone Disease. Kidney Int, 70 (5): 835–839. https://doi.org/10.1038/sj.ki.5001656
Taylor, E.N., Stampfer, M. J., & Curhan, G. C. 2005. Obesity, Weight Gain, and the Risk of Kidney Stones. JAMA, 293(4): 455–462. https://doi.org/10.1001/jama.293.4.455
Torricelli, F. C. M., De, S. K., Gebreselassie, S., Li, I., Sarkissian, C., & Monga, M. 2014. Dyslipidemia and Kidney Stone Risk. J Urol, 191(3): 667–672. https://doi.org/10.1016/j.juro.2013.09.022
Vupputuri, S., Soucie, J., McClellan, W., & Sandler, D. 2004. History of Kidney Stones as a Possible Risk Factor for Chronic Kidney Disease. Ann Epidemiol, 14 (3): 222–228. https://doi.org/10.1016/S1047-2797(03)00126-1
Wang, W., Fan, J., & Huang, G. 2017. Prevalence of Kidney Stones in Mainland China: A systematic Review. Sci Rep, 7(41630). https://doi.org/10.1038/srep41630
West, B., Luke, A., Durazo-Arvizu, R., Cao, G., Shoham, D., & Kramer, H. 2008. Metabolic Syndrome and Self-Reported History of Kidney Stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis, 51(5): 741–747. https://doi.org/10.1053/j.ajkd.2007.12.030
Wong, Y., Cook, P., Roderick, P., & Bk, S. 2016. Metabolic Syndrome and kidney stone disease : A systematic review of literature . Journal of Endourology, 30(3): 1–17. https://doi.org/10.1089/end.2015.0567
Yoshimura, E., et al. 2016. Body Mass Index and Kidney Stones: A Cohort Study of Japanese Men. J Epidemiol, 26(3): 131–136. https://doi.org/10.2188/jea.JE20150049
Zhao, A., Dai, M., Chen, Y., Chang, H., Liu, A., & Wang, P. 2012. Risk Factors Associated With Nephrolithiasis: A Case-Control Study in China. Asia-Pacific J Public Heal, 27(2). https://doi.org/10.1177/1010539512445189